Back to top
more

RadNet (RDNT)

(Real Time Quote from BATS)

$59.95 USD

59.95
530,258

+4.67 (8.45%)

Updated Aug 6, 2024 02:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (69 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Zacks Industry Outlook Highlights DaVita, Encompass Health, Option Care Health and RadNet

by Zacks Equity Research

DaVita, Encompass Health, Option Care Health and RadNet are part of the Zacks Industry Outlook article.

4 Stocks to Buy in a Booming Outpatient Home Health Industry

by Zacks Equity Research

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and RDNT are well-poised to gain.

Best Momentum Stocks to Buy for August 15th

by Zacks Equity Research

DFH, RDNT and PNNT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 15, 2023.

RadNet (RDNT) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of 242.86% and 3.80%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 260% and 2.03%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

RadNet (RDNT) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of -14.29% and 5.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Indrajit Bandyopadhyay headshot

3 Medical Device Stocks With Potential to Fight Recession Risk

by Indrajit Bandyopadhyay

Increasing interest rates, higher costs and rising unemployment paint an unfavorable picture with the risk of a recession looming large. Here we discuss three medical stocks that may be good bets even in a recession.

Zacks Industry Outlook Highlights Chemed, Addus HomeCare, RadNet and The Pennant Group

by Zacks Equity Research

Chemed, Addus HomeCare, RadNet and The Pennant Group are part of the Zacks Industry Outlook article.

Debanjana Dey headshot

4 Promising Stocks From a Challenging Outpatient Home Health Industry

by Debanjana Dey

Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. CHE, ADUS, RDNT and PNTG are well poised to gain from the prospects.

Why Fast-paced Mover RadNet (RDNT) Is a Great Choice for Value Investors

by Zacks Equity Research

RadNet (RDNT) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Are Investors Undervaluing RadNet (RDNT) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

RadNet (RDNT) Misses Q4 Earnings Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of -42.11% and 11.24%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Rimmi Singhi headshot

5 Toxic Stocks That Can Set Off Alarm Bells for Your Portfolio

by Rimmi Singhi

Investors who can correctly spot overpriced stocks and shun them at the right time can avoid big losses. Dump toxic stocks like MGM, ILMN, OMCL, HL and RDNT to prevent portfolio bleeding.

RadNet (RDNT) Misses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of -43.75% and 0.04%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 25% and 0.02%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Encompass Health (EHC) Q3 Earnings Miss Estimates

by Zacks Equity Research

Encompass Health (EHC) delivered earnings and revenue surprises of -1.47% and 2.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Is RadNet (RDNT) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Quest Diagnostics (DGX) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

RadNet (RDNT) Stock Jumps 16%: Will It Continue to Soar?

by Zacks Equity Research

RadNet (RDNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Is Quest Diagnostics (DGX) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

RadNet (RDNT) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of 200% and 1.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Chemed (CHE) Q2 Earnings Surpass Estimates

by Zacks Equity Research

Chemed (CHE) delivered earnings and revenue surprises of 1.26% and 1.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Trina Mukherjee headshot

3 Stocks to Watch From a Buoyant Outpatient Home Health Industry

by Trina Mukherjee

Despite the COVID-19 pandemic-induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, RDNT and USPH are well-poised to gain from the prospects.

RadNet (RDNT) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of -650% and 1.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

RadNet (RDNT) Q4 Earnings and Revenues Miss Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of -31.58% and 4.26%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?